People's Hospital of Ningxia, China
Idiopathic granulomatous mastitis (IGM) has been a worldwide problem due to its sudden onset, rapid progression, difficulty of curing, long course, and susceptibility to recurrence and reoccurrence. The average age of the disease is 32 years. The clinical manifestation of breast lumps with painful ulceration has been treated with surgical excision, incision and drainage, hormone and 3 anti-TB treatments. The recurrence rate is 73% and it easily leads to disfiguration. Our group has independently developed minimally invasive cleansing and breast-conserving technology for granulomatous mastitis, which is caused by the immunochemical reaction to the old milk and fluid accumulation in the milk ducts, resulting in necrosis from the inside out. And based on clinical typing and staging, we individualized minimally invasive cleansing technology through lactoscopy, assisted with vacuum rotary cut, liposuction and scraping spoon, intravenous indwelling needle, syringe single or combined with inside-out flushing combined with Chinese medicine formula organism conditioning cream topical application of the ruptured surface to repair the inflammatory area to achieve the clinical effect of complete scarless healing . The whole process was led by ultrasound with a 2mm opening and a 0.6mm needle retention, which is in line with the era of precise micro-innovation medical treatment. In addition to avoiding defect of breast tissue removal, the treatment is simple, less traumatic or painful and it is economical and practical. It preserves the breasts and eliminates recurrence and avoids re-occurrence. It is the first of its kind in China to reform the traditional surgery.
Hongli Wu is a semi-retired chief surgeon who specializes in breast ductoscopy and treatment of breast duct disease. She has developed a minimally invasive breast-conserving method with good results for the persistent breast disease plasma cell mastitis. She has a unique expertise in the differential diagnosis of breast cancer and the treatment of benign breast diseases and has presided over the completion of three regional and municipal scientific research projects.